Presentation

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: Harvey D. White

October 30, 2016

REGISTER for free or LOG IN to view this content

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Coronary

Presentation

TCT 2016

CAD Pharma

Up Next

Presentation

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in A Bayesian Framework!

Presenter: Scott Berry

October 30, 2016

More slides +

Presentation

Points to Consider in the Review of Endovascular Treatment Devices: US Regulatory View

Presenter: Eleni Whatley

October 30, 2016

Presentation

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

Presenter: JoAnn Lindenfeld

October 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.